Arotech Corporation (NASDAQ:ARTX) has been upgraded to Hold in a report by Zacks Investment Research earlier today.
- Updated: October 16, 2016
Zacks Investment Research has upgraded Arotech Corporation (NASDAQ:ARTX) to Hold in a report released on 10/11/2016.
Previously on 08/12/2015, B. Riley reported about Arotech Corporation (NASDAQ:ARTX) raised the target price from $0.00 to $4.00. At the time, this indicated a possible upside of 1.5%.
Only yesterday Arotech Corporation (NASDAQ:ARTX) traded -0.95% lower at $3.44. ARTX’s 50-day average is $3.02 and its 200-day moving average is $2.95. With the last close up 5.62% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the date range. Volume of trade was up over the average, with 216,331 shares of ARTX changing hands over the typical 202,218
With a total market value of $0, Arotech Corporation has 52 week low of $1.35 and a 52 week high of $4.13 .
About Arotech Corporation (NASDAQ:ARTX)
Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division. The Company's Training and Simulation Division develops, manufactures and markets multimedia and interactive digital solutions for engineering, use-of-force training and operator training of military, law enforcement, security, emergency services and other personnel. The Company's Power Systems Division provides battery solutions, energy management and power distribution technologies and product design and manufacturing services for the aerospace, defense, law enforcement, homeland security markets, and it manufactures and sells rechargeable batteries for defense and security products and medical and industrial applications.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.